LYMPHOHISTIOCYTOSIS

LYMPHOHISTIOCYTOSIS was reported 75 times

LYMPHOHISTIOCYTOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD52-directed Cytolytic Antibody [EPC] 6 0.0003
1 Topoisomerase Inhibitor [EPC] 9 0.0001
2 Purine Antimetabolite [EPC] 9 0.0001
3 Interleukin-1 Receptor Antagonist [EPC] 1 0.0001
4 Calcineurin Inhibitor Immunosuppressant [EPC] 6 0.0000
5 Cardiac Glycoside [EPC] 3 0.0000
6 Alkaloid [EPC] 1 0.0000
7 Folate Analog Metabolic Inhibitor [EPC] 11 0.0000
8 Alkylating Drug [EPC] 6 0.0000
9 Angiotensin Converting Enzyme Inhibitor [EPC] 3 0.0000
10 Tumor Necrosis Factor Blocker [EPC] 20 0.0000
11 Aminosalicylate [EPC] 2 0.0000
12 Aldosterone Antagonist [EPC] 3 0.0000
13 Macrolide Antimicrobial [EPC] 1 0.0000
14 Corticosteroid [EPC] 24 0.0000
15 Methylxanthine [EPC] 1 0.0000
16 Nitroimidazole Antimicrobial [EPC] 1 0.0000
17 Tetracycline-class Drug [EPC] 1 0.0000
18 Anti-epileptic Agent [EPC] 3 0.0000
19 Nucleoside Analog Antiviral [EPC] 1 0.0000
20 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
21 Mood Stabilizer [EPC] 2 0.0000
22 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
23 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
24 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
25 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
26 Leukocyte Growth Factor [EPC] 1 0.0000
27 Loop Diuretic [EPC] 3 0.0000
28 Azole Antifungal [EPC] 1 0.0000
29 Proton Pump Inhibitor [EPC] 3 0.0000
30 Nonsteroidal Anti-inflammatory Drug [EPC] 5 0.0000
31 Opioid Agonist [EPC] 1 0.0000
32 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
33 Benzodiazepine [EPC] 2 0.0000